122 related articles for article (PubMed ID: 30732960)
1. Cost-effectiveness analysis of the oral cancer screening program in Taiwan.
Huang CC; Lin CN; Chung CH; Hwang JS; Tsai ST; Wang JD
Oral Oncol; 2019 Feb; 89():59-65. PubMed ID: 30732960
[TBL] [Abstract][Full Text] [Related]
2. Life expectancy and expected years of life lost to oral cancer in Taiwan: a nation-wide analysis of 22,024 cases followed for 10 years.
Huang CC; Ou CY; Lee WT; Hsiao JR; Tsai ST; Wang JD
Oral Oncol; 2015 Apr; 51(4):349-54. PubMed ID: 25604257
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data.
Lin CN; Lee KT; Chang SM; Wang JD
J Formos Med Assoc; 2022 Mar; 121(3):633-642. PubMed ID: 34246512
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.
Chen PC; Lee JC; Wang JD
PLoS One; 2015; 10(7):e0133755. PubMed ID: 26207912
[TBL] [Abstract][Full Text] [Related]
5. Lifetime risks, expected years of life lost, and cost-per-life year of esophageal cancer in Taiwan.
Lai WW; Lin CN; Chang CC; Wang JD
Sci Rep; 2020 Feb; 10(1):3722. PubMed ID: 32111930
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan.
Liao CT; Hsieh TH; Shih CY; Liu PY; Wang JD
Sci Rep; 2021 Mar; 11(1):5608. PubMed ID: 33692425
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of cancer treatment in Taiwan.
Hung MC; Lai WW; Chen HH; Lee JC; Lin YJ; Hsiao JR; Cheng YM; Shan YS; Su WC; Wang JD
J Formos Med Assoc; 2016 Aug; 115(8):609-18. PubMed ID: 27302557
[TBL] [Abstract][Full Text] [Related]
9. Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan.
Wu TY; Chung CH; Lin CN; Hwang JS; Wang JD
Clin Epidemiol; 2018; 10():581-591. PubMed ID: 29872347
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus.
van der Meij EH; Bezemer PD; van der Waal I
Community Dent Oral Epidemiol; 2002 Oct; 30(5):342-51. PubMed ID: 12236825
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
12. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in Adolescent Girls in Taiwan.
Tang CH; Cheng WF; Jiang JH; You SL; Huang LW; Hsieh JY; Mukherjee P; Van Kriekinge G; Lee C
Asian Pac J Cancer Prev; 2019 May; 20(5):1377-1387. PubMed ID: 31127896
[TBL] [Abstract][Full Text] [Related]
14. Factors that affect life expectancy of patients with gastric adenocarcinoma.
Chen WY; Cheng HC; Wang JD; Sheu BS
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1595-600. PubMed ID: 23811250
[TBL] [Abstract][Full Text] [Related]
15. Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002-2009.
Hung MC; Liu MT; Cheng YM; Wang JD
BMC Cancer; 2014 Jul; 14():505. PubMed ID: 25011933
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori test-and-treat program can be cost-effective to prevent gastric cancer in Taiwanese adults: referred to the nationwide reimbursement database.
Cheng HC; Wang JD; Chen WY; Chen CW; Chang SC; Sheu BS
Helicobacter; 2015 Apr; 20(2):114-24. PubMed ID: 25382169
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
18. The cost-effectiveness of screening for oral cancer in primary care.
Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
[TBL] [Abstract][Full Text] [Related]
19. Estimation of life expectancy, loss-of-life expectancy, and lifetime healthcare expenditures for schizophrenia in Taiwan.
Lêng CH; Chou MH; Lin SH; Yang YK; Wang JD
Schizophr Res; 2016 Mar; 171(1-3):97-102. PubMed ID: 26811230
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of Korea's National Cervical Cancer Screening Program.
Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
Asian Pac J Cancer Prev; 2013; 14(7):4329-34. PubMed ID: 23991998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
